Functional MRCP in pancreatic and periampullary disease

International Journal of Gastrointestinal Cancer

Volumn 30, Issue 1-2, 2001, Pages 5-18

  Matos, Celso ^a   Winant, Catherine ^a   Delhaye, Myriam ^a   Devière, Jacques ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Magnetic resonance cholangiopancreatography (MRCP); Pancreas, function; Pancreas, MR; Pancreatic ducts, MR; Pancreatitis; Secretin

Indexed keywords

SECRETIN;

ACUTE PANCREATITIS; CHRONIC PANCREATITIS; DIAGNOSTIC IMAGING; DISEASE COURSE; DYNAMICS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; EXOCRINE CELL; FOLLOW UP; HEPATOBILIARY SYSTEM; HUMAN; IMAGE ANALYSIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREAS CARCINOMA; PANCREAS DISEASE; PANCREAS DUCT; PANCREAS FUNCTION; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

EID: 0035787253     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:30:1-2:005     Document Type: Review

References (27)

1. Bolondi L, Gaiani S, Gullo L, Labò G. Secretin administration induces a dilatation of the main pancreatic duct. Dig Dis Sci 1984;29:802-808.
2. Glaser J, Hogemann B, Krummenerl T, et al. Sonographic imaging of the pancreatic duct/new possibilities using secretin stimulation. Dig Dis Sci 1987;32:1075-1081.
3. Glaser J, Hogemann B, Schneider M, et al. Significance of a sonographic secretin test in the diagnosis of pancreatic diseases: results of a prospective study. Scand J Gastroenterol 1989;24:174-185.
4. Lowes JR, Lees WR, Cotton PB. Pancreatic duct dilatation after secretin stimulation in patients with pancreas divisum. Pancreas 1989;4:371-374.
5. Cavallini G, Rigo L, Bovo P, et al. Abnormal US response of main pancreatic duct after secretin stimulation in patients with acute pancreatitis of different etiology. J Clin Gastroenterol 1994;18:298-303.
6. Matos C, Metens T, Devière J, et al. Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 1997;203:435-441.
7. Manfredi R, Costamagna G, Brizi MG, et al. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 2000;214:849-855.
8. Manfredi R, Costamagna G, Brizi MG, et al. Pancreas divisum and santorinicele: diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Radiology 2000;217:403-408.
9. Matos C, Metens T, Devière J, et al. Pancreas divisum: evaluation with secretin-enhanced magentic resonance cholangiopancreatography. Gastrointest Endosc 2001;53:728-733.
10. Cappeliez O, Delhaye M, Devière J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000;215:358-364.
11. Heverhagen JT, Muller D, Battmann A, et al. MR hydrometry to assess exocrine function of the pancreas: initial results of non invasive quantification of secretion. Radiology 2001;218:61-67.
12. Nanashima A, Yamagushi H, Fukuda T, et al. Evaluation of pancreatic secretion after administration of secretin: application of magnetic resonance imaging. J Gastroenterol Hepatol 2001;16:87-92.
13. Dreiling DA, Messer J. The secretin story. Am J Gastroenterol 1978;70:455-479.
14. Takehara Y. Fast MR imaging for evaluating the pancreaticobiliary system. Eur J Radiol 1999;29:211-232.
15. Laugier R. Dynamic endoscopic manometry of the response to secretin in patients with chronic pancreatitis. Endoscopy 1994;26:222-227.
16. Matos C, Cappeliez O, Winant C, et al. MR imaging of the pancreas: a pictorial tour. Radiographics 2002;22(1):E2.
17. Hastier P, Buckley MJ, Dumas R, et al. A study of the effect of age on pancreatic duct morphology. Gastrointest Endosc 1998;48:53-57.
18. Mariani A, Curioni S, Zanello A, et al. Does aging influence the main pancreatic duct diameter measured by MR pancreatography? Digest Liver Dis 2000;32:A107.
19. Masui T, Katayama M, Kobayashi S, et al. Functional assessment of pancreatic parenchyma after secretin administration using serial T2-weighted echo-planar magnetic resonance imaging. J Magn Reson Imaging 2001;14:450-456.
20. Matos C, Nicaise N, Devière J, et al. Choledochal cysts: comparison of findings at magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography in eight patients. Radiology 1998;209:443-448.
21. Matos C, Devière J, Cremer M, et al. Acinar filling during secretin-stimulated MR pancreatography. AJR 1998;171:165-169.
22. Koito K, Namieno T, Ichimura T, et al. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Radiology 1998;208:231-237.
23. Lecesne R, Taourel P, Bret PM, et al. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999;211:727-735.
24. Morgan DE, Baron TH, Smith JK, et al. Pancreatic fluid collections prior to intervention: evaluation with MR imaging compared with CT and US. Radiology 1997;203:773-778.
25. Neoptolemos JP, London NJ, Carr-Locke DL. Assessment of main pancreatic duct integrity by endoscopic retrograde pancreatography in patients with acute pancreatitis. Br J Surg 1993;80:94-99.
26. Axon ATR, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut 1984;25:1107-1112.
27. Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 2001;221:107-116.